ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,325.295
-0.09%
Brent Oil
80.855
0.06%
Bitcoin
67,651.62
-0.14%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. IVERIC bio Inc (ISEE)

  7. IVERIC bio Inc (ISEE) News

IVERIC bio (ISEE)

IVERIC bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ISEE
DateTimeSourceHeadlineSymbolCompany
14/02/202413:49Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ISEEIVERIC bio Inc
21/07/202313:30Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:ISEEIVERIC bio Inc
18/07/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ISEEIVERIC bio Inc
13/07/202319:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ISEEIVERIC bio Inc
13/07/202319:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ISEEIVERIC bio Inc
13/07/202319:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ISEEIVERIC bio Inc
13/07/202318:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ISEEIVERIC bio Inc
13/07/202318:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ISEEIVERIC bio Inc
13/07/202318:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ISEEIVERIC bio Inc
13/07/202318:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ISEEIVERIC bio Inc
13/07/202318:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ISEEIVERIC bio Inc
13/07/202318:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ISEEIVERIC bio Inc
13/07/202318:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ISEEIVERIC bio Inc
12/07/202300:00PR Newswire (US)Astellas Completes Acquisition of Iveric BioNASDAQ:ISEEIVERIC bio Inc
11/07/202315:13Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ISEEIVERIC bio Inc
11/07/202315:12Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ISEEIVERIC bio Inc
11/07/202315:12Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ISEEIVERIC bio Inc
11/07/202315:11Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ISEEIVERIC bio Inc
11/07/202315:11Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ISEEIVERIC bio Inc
11/07/202315:10Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ISEEIVERIC bio Inc
11/07/202315:10Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ISEEIVERIC bio Inc
11/07/202315:09Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ISEEIVERIC bio Inc
11/07/202315:08Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ISEEIVERIC bio Inc
11/07/202315:08Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ISEEIVERIC bio Inc
11/07/202315:07Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ISEEIVERIC bio Inc
11/07/202315:06Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ISEEIVERIC bio Inc
11/07/202315:06Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ISEEIVERIC bio Inc
11/07/202315:05Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ISEEIVERIC bio Inc
11/07/202315:04Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ISEEIVERIC bio Inc
11/07/202315:04Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ISEEIVERIC bio Inc
 Showing the most relevant articles for your search:NASDAQ:ISEE

Your Recent History

LSE
SHEL
Shell
LSE
TLY
Totally
LSE
GGP
Greatland Gold
LSE
BOO
Boohoo
LSE
UKOG
Uk Oil & Gas
LSE
HSBA
Hsbc
LSE
TSCO
Tesco
LSE
SCLP
Scancell
LSE
THG
Thg
LSE
LGEN
Legal & General
LSE
DEC
Diversified Energy
LSE
888
888
LSE
KEFI
Kefi Gold And Copper
LSE
YU.
Yu
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved